These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30408793)

  • 1. Effective Fetal Epigenetic Biomarkers for Noninvasive Fetal Trisomy 21 Detections.
    Lim JH; Lee BY; Kim JW; Han YJ; Kim MH; Chung JH; Han JY; Kim MY; Ryu HM
    Fetal Diagn Ther; 2019; 46(2):133-138. PubMed ID: 30408793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density.
    Lim JH; Lee DE; Kim KS; Kim HJ; Lee BY; Park SY; Ahn HK; Lee SW; Kim MY; Ryu HM
    Clin Chem Lab Med; 2014 May; 52(5):641-7. PubMed ID: 24353143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
    Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
    J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.
    Lim JH; Kim SY; Park SY; Lee SY; Kim MJ; Han YJ; Lee SW; Chung JH; Kim MY; Yang JH; Ryu HM
    PLoS One; 2011; 6(11):e27709. PubMed ID: 22132128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21.
    Lim JH; Lee DE; Park SY; Kim DJ; Ahn HK; Han YJ; Kim MY; Ryu HM
    BMC Med Genomics; 2014 Jan; 7():1. PubMed ID: 24397966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.
    Tong YK; Jin S; Chiu RW; Ding C; Chan KC; Leung TY; Yu L; Lau TK; Lo YM
    Clin Chem; 2010 Jan; 56(1):90-8. PubMed ID: 19850629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma.
    Lim JH; Lee BY; Kim JW; Han YJ; Chung JH; Kim MH; Kwak DW; Park SY; Choi HB; Ryu HM
    J Assist Reprod Genet; 2018 Apr; 35(4):637-641. PubMed ID: 29423788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
    Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
    Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
    Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker.
    Tong YK; Chiu RW; Akolekar R; Leung TY; Lau TK; Nicolaides KH; Lo YM
    PLoS One; 2010 Dec; 5(12):e15244. PubMed ID: 21249119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalic index is not a useful sonographic marker for trisomy 21 and trisomy 18.
    Lim KI; Delisle MF; Austin SJ; Wilson RD
    Fetal Diagn Ther; 2004; 19(6):491-5. PubMed ID: 15539873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.
    Ghi T; Arcangeli T; Ravennati F; Salsi G; Montaguti E; Pacella G; Maroni E; Pittalis MC; Pompilii E; Pilu G; Rizzo N
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):674-8. PubMed ID: 24866349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
    Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
    Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.
    Lim JH; Lee DE; Kim SY; Kim HJ; Kim KS; Han YJ; Kim MH; Choi JS; Kim MY; Ryu HM; Park SY
    J Assist Reprod Genet; 2015 May; 32(5):827-37. PubMed ID: 25749789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Urinary Peptidome as a Noninvasive Biomarker Development Strategy for Prenatal Screening of Down's Syndrome.
    Shan D; Wang H; Khatri P; Niu Y; Song W; Zhao S; Jiang Y; Ma Q; Liu X; Zhang R; Wang W; Yin C
    OMICS; 2019 Sep; 23(9):439-447. PubMed ID: 31381471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.